STOCK TITAN
  1. Home
  2. Sec-filings
  3. PMI
  4. [8-K] Picard Medical, Inc. Reports Material Event

Picard Medical (PMI) plans March 25 webcast on 2025 results and SynCardia

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Picard Medical, Inc. announced it will host a webcasted Annual Business Update on March 25, 2026 at 4:30 p.m. Eastern Time. During the event, management will review fiscal year and fourth quarter 2025 financial results, discuss operational progress, commercial activity, and strategic priorities.

The webcast will also feature perspectives from leading clinicians and a patient testimonial regarding the SynCardia Total Artificial Heart. Registration is available via a link in the company’s March 12, 2026 press release and on its website, with the press release furnished as Exhibit 99.1.

Positive

  • None.

Negative

  • None.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Understanding 8-K Material Events →
false 0002030617 0002030617 2026-03-12 2026-03-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): March 12, 2026

 

Picard Medical, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-42801   86-3212894

(State or other jurisdiction

of incorporation)

   (Commission
File Number)		  

(IRS Employer

Identification No.)

 

1992 E Silverlake
Tucson AZ, 85713
(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (520) 545-1234

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   PMI   The NYSE American, LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On March 12, 2026, Picard Medical, Inc. (the “Company”) issued a press release announcing that the Company will host a webcasted Annual Business Update on March 25, 2026 at 4:30p.m. Eastern Time. As discussed in the press release, the webcast will include management’s review of fiscal year and fourth quarter 2025 financial results and a business overview addressing operational progress, commercial activity, and strategic priorities, as well as perspectives from leading clinicians and a patient testimonial regarding the SynCardia Total Artificial heart. Registration for the webcast is available via a link in the press release furnished herewith as Exhibit 99.1 and is also accessible through the Company’s website at www.picardmedical.com. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

The information in this report and the exhibits attached hereto shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

  (d) Exhibits

 

The following exhibits are being furnished herewith:

 

Exhibit No.   Description
99.1   Picard Medical, Inc. Press Release dated March 12, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Picard Medical, Inc.  
   
By: /s/ Patrick NJ Schnegelsberg  
  Name: Patrick NJ Schnegelsberg  
  Title: Chief Executive Officer  

 

Dated: March 12, 2026

 

2

Source: View Original Filing on SEC EDGAR

FAQ

What did Picard Medical (PMI) announce in this 8-K filing?

Picard Medical announced it will host a webcasted Annual Business Update on March 25, 2026. Management will review fiscal year and fourth quarter 2025 financial results and discuss operational progress, commercial activity, strategic priorities, and perspectives on the SynCardia Total Artificial Heart.

When is Picard Medical’s 2026 webcasted Annual Business Update?

The webcasted Annual Business Update is scheduled for March 25, 2026 at 4:30 p.m. Eastern Time. The event will cover fiscal year and fourth quarter 2025 results, operational progress, commercial initiatives, strategic priorities, and include clinician perspectives and a patient testimonial.

What topics will Picard Medical (PMI) cover during the Annual Business Update?

The Annual Business Update will cover fiscal year and fourth quarter 2025 financial results, operational progress, commercial activity, and strategic priorities. It will also include insights from leading clinicians and a patient testimonial focused on the SynCardia Total Artificial Heart platform.

How can investors register for Picard Medical’s March 25, 2026 webcast?

Investors can register for the webcast through a link provided in Picard Medical’s March 12, 2026 press release. The registration link is also accessible via the company’s website at www.picardmedical.com, allowing convenient online sign-up for the event.

What is Exhibit 99.1 in Picard Medical’s March 12, 2026 8-K?

Exhibit 99.1 is Picard Medical’s press release dated March 12, 2026. The release announces the webcasted Annual Business Update, provides the registration link, and describes that the event will include financial review, business overview, and SynCardia Total Artificial Heart perspectives.

Does this Picard Medical 8-K indicate the information is filed or furnished?

The 8-K specifies that the information and attached exhibits are furnished, not filed, under the Exchange Act. This means they are not subject to certain liabilities and are not automatically incorporated by reference into Securities Act or Exchange Act filings.

Filing Exhibits & Attachments

4 documents

Press Releases

Other Documents